- Home
- PONY vs VCEL Comparison
PONY vs VCEL Comparison
Compare PONY & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PONY
- VCEL
- Stock Information
- Founded
- PONY 2016
- VCEL 1989
- Country
- PONY China
- VCEL United States
- Employees
- PONY N/A
- VCEL N/A
- Industry
- PONY
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PONY
- VCEL Health Care
- Exchange
- PONY NYSE
- VCEL Nasdaq
- Market Cap
- PONY 1.8B
- VCEL 2.1B
- IPO Year
- PONY 2024
- VCEL 1997
- Fundamental
- Price
- PONY $17.93
- VCEL $41.73
- Analyst Decision
- PONY Strong Buy
- VCEL Strong Buy
- Analyst Count
- PONY 3
- VCEL 8
- Target Price
- PONY $19.20
- VCEL $61.75
- AVG Volume (30 Days)
- PONY 17.9M
- VCEL 517.5K
- Earning Date
- PONY 05-20-2025
- VCEL 05-08-2025
- Dividend Yield
- PONY N/A
- VCEL N/A
- EPS Growth
- PONY N/A
- VCEL 521.85
- EPS
- PONY N/A
- VCEL 0.05
- Revenue
- PONY $75,025,000.00
- VCEL $238,541,000.00
- Revenue This Year
- PONY $18.18
- VCEL $23.23
- Revenue Next Year
- PONY $81.32
- VCEL $24.41
- P/E Ratio
- PONY N/A
- VCEL $800.69
- Revenue Growth
- PONY 4.35
- VCEL 14.80
- 52 Week Low
- PONY $4.11
- VCEL $37.39
- 52 Week High
- PONY $23.88
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- PONY N/A
- VCEL 51.56
- Support Level
- PONY N/A
- VCEL $37.48
- Resistance Level
- PONY N/A
- VCEL $39.42
- Average True Range (ATR)
- PONY 0.00
- VCEL 1.84
- MACD
- PONY 0.00
- VCEL 0.57
- Stochastic Oscillator
- PONY 0.00
- VCEL 77.71
About PONY PONY AI INC SPON ADS EACH REP 1 COM CL A
Pony AI Inc is an artificial intelligence technology company that principally engaged in the operation and development of autonomous vehicles. It operate fully driverless robotaxis through PonyPilot mobile app in Beijing, Shanghai, Guangzhou and Shenzhen. The company operate a fleet of nearly 250 robotaxis. The Group conducts its operation mainly in the People's Republic of China (PRC) and the United States of America (U.S.) through subsidiaries. Key revenue is generated from People's Republic of China.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.